CIPII is not indicated in cases of patients with high circulating levels of insulin autoantibodies, poor therapy compliance, evidence of psychiatric conditions, gastrointestinal disorders (e.g., colon diseases, peritoneal adhesions), and unsuitability for external pump use in CSII (1). This evidence concerns the gene INS and digestive system disorder.